GALENA BIOPHARMA INC COM
RXII
RXII was delisted on the 25th of October, 2011.
79 hedge funds and large institutions have $33.6M invested in GALENA BIOPHARMA INC COM in 2014 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 16 closing their positions.
7% less funds holding
Funds holding: 85 → 79 (-6)
13% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 23
25% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 16
25% less capital invested
Capital invested by funds: $45M → $33.6M (-$11.4M)
37% less call options, than puts
Call options by funds: $3.09M | Put options by funds: $4.86M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$658K |
| 2 |
SIM
Spark Investment Management
New York
|
+$462K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$374K |
| 4 |
Millennium Management
New York
|
+$325K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$292K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$1.14M |
| 2 |
HCA
Harbour Capital Advisors
Tysons Corner,
Virginia
|
-$236K |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$214K |
| 4 |
MLICM
Metropolitan Life Insurance Company (MetLife)
New York
|
-$203K |
| 5 |
TNB
Thomasville National Bank
Thomasville,
Georgia
|
-$195K |
RXII Hedge Fund Activity: Q4 2014 in Review
79 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in GALENA BIOPHARMA INC COM (RXII) for Q4 2014, worth a combined $33.6M — down 25% from $45M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of RXII and 12 opened new positions — a net loss of 4 holders — while 23 trimmed existing stakes and 20 added.
The largest buyer was BlackRock Fund Advisors, adding an estimated $658K. The largest seller was Smith Group Asset Management, exiting entirely with an estimated $1.14M sold.
- 79 institutional investors held GALENA BIOPHARMA INC COM (RXII) as of Q4 2014, down from 85 in Q3 2014.
- Funds reported $33.6M of GALENA BIOPHARMA INC COM stock for Q4 2014, down 25% quarter-over-quarter.
- 12 funds opened new GALENA BIOPHARMA INC COM positions in Q4 2014 and 16 closed out, a net change of -4 holders.
- The largest GALENA BIOPHARMA INC COM buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $658K added.
- The largest GALENA BIOPHARMA INC COM seller in Q4 2014 was Smith Group Asset Management, an estimated $1.14M sold.
Based on aggregated 13F filings for Q4 2014.